Oxime carbamate--discovery of a series of novel FAAH inhibitors

Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. doi: 10.1016/j.bmcl.2009.11.080. Epub 2009 Nov 24.

Abstract

A series of novel oxime carbamates have been identified as potent inhibitors of the key regulatory enzyme of the endocannabinoid signaling system, fatty acid amide hydrolase (FAAH). In this Letter, the rationale behind the discovery and the biological evaluations of this novel class of FAAH inhibitors are presented. Both in vitro and in vivo results of selected targets are discussed, along with inhibition kinetics and molecular modeling studies.(1).

Publication types

  • Comparative Study

MeSH terms

  • Amidohydrolases / antagonists & inhibitors*
  • Amidohydrolases / physiology
  • Animals
  • Cannabinoid Receptor Modulators / physiology
  • Carbamates / chemistry*
  • Carbamates / metabolism
  • Carbamates / pharmacology
  • Cell Line
  • Crystallography, X-Ray
  • Drug Discovery / methods*
  • Humans
  • Oximes / chemistry*
  • Oximes / metabolism
  • Oximes / pharmacology*
  • Protein Binding / physiology
  • Protein Structure, Tertiary
  • Rats
  • Signal Transduction / drug effects
  • Signal Transduction / physiology

Substances

  • Cannabinoid Receptor Modulators
  • Carbamates
  • Oximes
  • Amidohydrolases
  • fatty-acid amide hydrolase